India Daily Briefing

Alkem Laboratories promoter family entities sold approximately 1.5% stake in a ₹930 Crore block deal executed through Goldman Sachs and Morgan Stanley as placement agents, Economic Times Markets reported. The deal signals that promoter-family liquidity generation is picking up in the pharma midcap space, which has outperformed this year and given promoters a high price point to reduce concentration risk without impacting controlling stake. For SIP investors already holding Alkem, the institutional placement by Goldman/Morgan Stanley implies the secondary overhang is now absorbed — watch price behavior in the next two sessions to confirm buying absorption.

CMR Green Technologies raised ₹188 crore from anchor investors ahead of its Wednesday IPO opening, with SBI Mutual Fund and ICICI Prudential MF among the largest participants, Mint Markets confirmed. The anchor round — typically a signal of institutional confidence — was fully placed, a data point that contrasts with the cautious FII tone in secondary markets and suggests domestic institutional appetite for quality IPO paper remains strong. With anchor round done, Day 1 subscription data will determine whether retail participation matches institutional confidence; weak retail subscription despite anchor oversubscription has been the key failure mode in recent IPOs.

UK Foreign Secretary Yvette Cooper is visiting India soon with the proposed India-UK Free Trade Agreement as the centrepiece of discussions, ET Economy reported citing MEA sources. A concluded India-UK FTA would be the most significant bilateral trade deal for India since its signing with UAE and Australia, potentially opening preferential market access for Indian pharma, IT services, and textiles in the £900bn UK economy. Watch for sector-specific tariff concession details — pharma (Sun, Dr Reddy's, Cipla), IT services (TCS, Infosys), and textile exporters (Welspun) would be the largest equity beneficiaries if a deal is announced in H2 2026.